Caption Management, LLC Reneo Pharmaceuticals, Inc. Transaction History
Caption Management, LLC
- $9.8 Billion
- Q4 2024
A detailed history of Caption Management, LLC transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 410,100 shares of RPHM stock, worth $688,968. This represents 0.01% of its overall portfolio holdings.
Number of Shares
410,100Holding current value
$688,968% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
Others Institutions Holding RPHM
# of Institutions
4Shares Held
4.9MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.53MShares$4.26 Million63.0% of portfolio
-
Abingworth LLP London, X02.07MShares$3.48 Million1.6% of portfolio
-
Black Rock Inc. New York, NY294KShares$493,3330.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.53KShares$2,5630.0% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $41.1M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...